Boston Sci Initiates Controlled Launch of Acurate Neo 2 in Europe

Boston Sci Initiates Controlled Launch of Acurate Neo 2 in Europe

Source: 
Medical Devices and Diagnostics Industry
snippet: 

The Marlborough, MA-based company received CE mark for the valve in April. Boston Scientific gained access to Acurate when it closed its $435 million acquisition of Symetis.